Unknown

Dataset Information

0

Economic burden of fungal diseases in the United States.


ABSTRACT: We conservatively estimated the annual US fungal disease-related economic burden as $19.4 billion, including direct medical costs ($13.4 billion) of hospitalizations (n = 133 555) and outpatient visits (n = 13.4 million), $1.7 billion from absenteeism, and $4.3 billion from deaths (n = 7288). These findings underscore the need for fungal disease surveillance, treatment, and prevention efforts.

SUBMITTER: Benedict K 

PROVIDER: S-EPMC12281149 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Economic burden of fungal diseases in the United States.

Benedict Kaitlin K   Gold Jeremy A W JAW   Chiller Tom T   Lyman Meghan M  

Medical mycology 20250601 6


We conservatively estimated the annual US fungal disease-related economic burden as $19.4 billion, including direct medical costs ($13.4 billion) of hospitalizations (n = 133 555) and outpatient visits (n = 13.4 million), $1.7 billion from absenteeism, and $4.3 billion from deaths (n = 7288). These findings underscore the need for fungal disease surveillance, treatment, and prevention efforts. ...[more]

Similar Datasets

| S-EPMC10312916 | biostudies-literature
| S-EPMC12604229 | biostudies-literature
| S-EPMC8390595 | biostudies-literature
| S-EPMC6289633 | biostudies-literature
| S-EPMC10473801 | biostudies-literature
| S-EPMC8171800 | biostudies-literature
| S-EPMC8754384 | biostudies-literature
| S-EPMC7313233 | biostudies-literature
| S-EPMC11832852 | biostudies-literature